Background: Walking is the primary form of physical activity performed by people with Multiple Sclerosis (MS), therefore it is important to ensure the validity of tools employed to measure walking activity. The aim of this study was to assess the criterion validity of the activPAL3 activity monitor during overground walking in people with MS. Methods: Validity of the activPAL3 accelerometer was compared to video observation in 20 people moderately affected by MS. Participants walked 20-30m twice along a straight quiet corridor at a comfortable speed. Results: Inter-rater reliability of video observations was excellent (all intraclass correlations > 0.99). The mean difference (activPAL3- mean of raters) was -4.70 ± 9.09, -4.55 s ± 10.76 and ...
International audienceBackground: Walking disorders represent the most disabling condition in person...
Background: Assessing walking impairment in those with multiple sclerosis (MS) is common, however l...
Multiple Sclerosis (MS) is a demyelinating neurodegenerative disease of the central nervous system. ...
Background: Walking is the primary form of physical activity performed by people with Multiple Scler...
Walking is the primary form of physical activity performed by people with Multiple Sclerosis (MS), t...
Introduction There has been increased interest in the objective monitoring of free-living walking b...
There has been increased interest in the objective monitoring of free-living walking behavior using ...
Introduction: There has been increased interest in the objective monitoring of free-living walking b...
PURPOSE: The purpose was to evaluate the psychometric properties of physical activity measures in pe...
Background: Persons with multiple sclerosis (MS) commonly have difficulty walking. The 6-Minute Walk...
Background: Gait deficits are common in multiple sclerosis (MS) and contribute to disability but may...
Background This study aims to verify the feasibility of use of wearable accelerometers in an ambu...
Approximately 33 million American adults had a movement disorder associated with medication use, ear...
Background: The gold standards for assessing ambulation are the Expanded Disability Status Scale (ED...
Supplementary Material: The Supplementary Material for this article can be found online at: https:...
International audienceBackground: Walking disorders represent the most disabling condition in person...
Background: Assessing walking impairment in those with multiple sclerosis (MS) is common, however l...
Multiple Sclerosis (MS) is a demyelinating neurodegenerative disease of the central nervous system. ...
Background: Walking is the primary form of physical activity performed by people with Multiple Scler...
Walking is the primary form of physical activity performed by people with Multiple Sclerosis (MS), t...
Introduction There has been increased interest in the objective monitoring of free-living walking b...
There has been increased interest in the objective monitoring of free-living walking behavior using ...
Introduction: There has been increased interest in the objective monitoring of free-living walking b...
PURPOSE: The purpose was to evaluate the psychometric properties of physical activity measures in pe...
Background: Persons with multiple sclerosis (MS) commonly have difficulty walking. The 6-Minute Walk...
Background: Gait deficits are common in multiple sclerosis (MS) and contribute to disability but may...
Background This study aims to verify the feasibility of use of wearable accelerometers in an ambu...
Approximately 33 million American adults had a movement disorder associated with medication use, ear...
Background: The gold standards for assessing ambulation are the Expanded Disability Status Scale (ED...
Supplementary Material: The Supplementary Material for this article can be found online at: https:...
International audienceBackground: Walking disorders represent the most disabling condition in person...
Background: Assessing walking impairment in those with multiple sclerosis (MS) is common, however l...
Multiple Sclerosis (MS) is a demyelinating neurodegenerative disease of the central nervous system. ...